100+ Free BCNSP Practice Questions

Pass your Board Certified Nutrition Support Pharmacist exam on the first try — instant access, no signup required.

✓ No registration✓ No credit card✓ No hidden fees✓ Start practicing immediately

100+ Questions

100% Free

1 / 100

Question 1

Score: 0/0

Which laboratory value is the most reliable indicator of visceral protein status for nutrition assessment in a hospitalized patient?

C-reactive protein

Serum albumin

Serum transferrin

Serum prealbumin (transthyretin)

to track

Same family resources

Explore More BPS Pharmacy Specialty Certifications

Continue into nearby exams from the same family. Each card keeps practice questions, study guides, flashcards, videos, and articles in one place.

More From This Family

Videos and articles for deeper review.

ArticleBCACP Exam Guide 2026: Ambulatory Care Pharmacy Prep8 min read ArticleFREE BCOP Exam Guide 2026: Oncology Pharmacist Prep10 min read ArticleFREE BCPS Exam Guide 2026: BPS Pharmacotherapy Cert20 min read ArticleFREE NABP FPGEE Exam Guide + Pass Plan (2026)20 min read

2026 Statistics

Key Facts: BCNSP Exam

150

Total Questions

125 scored + 25 unscored (Feb 2025 specs)

3h 45m

Exam Time

BPS BCNSP specifications (2025)

53%

Therapeutics Domain

Largest content domain

$600

Exam Fee

BPS fee schedule (2026)

7 years

Certification Valid

BPS recertification cycle

3 years

Practice Requirement

50%+ time in nutrition support

The BCNSP exam uses 150 items (125 scored + 25 unscored) administered over 3 hours 45 minutes with BPS scaled scoring (200-800). The Feb 2025 content outline weights Nutrition Support at 21%, Therapeutics and Patient Management at 53%, and Professional Practice at 26%. BPS charges $600 for initial certification and $300 for retakes. Eligibility requires an active pharmacist license plus 3 years nutrition support practice (50%+ time) or a PGY2 in Nutrition Support Pharmacy. Certification is valid for 7 years.

Sample BCNSP Practice Questions

Try these sample questions to test your BCNSP exam readiness. Each question includes a detailed explanation. Start the interactive quiz above for the full 100+ question experience with AI tutoring.

1A patient with short bowel syndrome has 80 cm of remaining jejunum with an intact colon. Which enteral formulation characteristic is most appropriate for this patient?

A.High-fat, low-carbohydrate polymeric formula

B.Peptide-based semi-elemental formula with medium-chain triglycerides

C.Standard fiber-enriched polymeric formula

D.Modular protein-only supplement

Explanation: Peptide-based semi-elemental formulas with MCTs are preferred in short bowel syndrome because peptides are more efficiently absorbed in reduced intestinal surface area, and MCTs are absorbed directly into the portal circulation without requiring bile salt emulsification. An intact colon allows for some colonic fermentation of malabsorbed carbohydrates, but the primary goal is optimizing proximal absorption.

2Which laboratory value is the most reliable indicator of visceral protein status for nutrition assessment in a hospitalized patient?

A.Serum albumin

B.Serum prealbumin (transthyretin)

C.Serum transferrin

D.C-reactive protein

Explanation: Prealbumin (transthyretin) has a short half-life of approximately 2-3 days, making it more responsive to acute changes in nutritional status compared to albumin (half-life ~20 days) or transferrin (half-life ~8-10 days). However, prealbumin is also affected by inflammation and should be interpreted alongside inflammatory markers like CRP.

3According to ASPEN guidelines, what is the recommended protein intake for a critically ill adult patient with a BMI of 28 kg/m²?

A.0.6-0.8 g/kg actual body weight/day

B.1.2-2.0 g/kg actual body weight/day

C.2.5-3.0 g/kg ideal body weight/day

D.0.8-1.0 g/kg ideal body weight/day

Explanation: ASPEN/SCCM guidelines recommend 1.2-2.0 g/kg actual body weight per day of protein for critically ill adults. Higher protein provision supports wound healing, immune function, and preservation of lean body mass during the catabolic stress response. For a patient with BMI 28 (non-obese), actual body weight is appropriate for dosing.

4A patient on parenteral nutrition develops a serum triglyceride level of 450 mg/dL. What is the most appropriate action regarding the intravenous lipid emulsion (IVLE)?

A.Continue IVLE at the current rate and recheck triglycerides in 48 hours

B.Reduce or hold IVLE and recheck serum triglycerides

C.Discontinue all parenteral nutrition immediately

D.Switch to a 30% IVLE concentration to reduce volume

Explanation: When serum triglycerides exceed 400 mg/dL during PN therapy, ASPEN recommends reducing the IVLE dose or temporarily holding it and rechecking levels. Hypertriglyceridemia during PN increases the risk of pancreatitis. The goal is to maintain triglycerides below 400 mg/dL while still providing essential fatty acids to prevent deficiency.

5Which of the following is the primary mechanism of essential fatty acid deficiency (EFAD) prevention when using soybean oil-based intravenous lipid emulsions?

A.Provision of omega-3 fatty acids (EPA and DHA)

B.Provision of linoleic acid (omega-6 fatty acid)

C.Provision of oleic acid (omega-9 fatty acid)

D.Provision of medium-chain triglycerides

Explanation: Soybean oil-based IVLE (e.g., Intralipid) prevents EFAD primarily by providing linoleic acid, an essential omega-6 fatty acid. Linoleic acid cannot be synthesized by the body and must be supplied exogenously. A minimum of 2-4% of total calories from linoleic acid is needed to prevent EFAD. The triene-to-tetraene ratio greater than 0.2 indicates EFAD.

6A critically ill patient is receiving continuous enteral nutrition at goal rate. The nurse reports a gastric residual volume (GRV) of 350 mL. Based on current ASPEN/SCCM guidelines, what is the recommended action?

A.Immediately stop enteral nutrition and switch to parenteral nutrition

B.Hold enteral feeding for 6 hours and recheck residuals

C.Continue enteral nutrition and avoid routine GRV monitoring

D.Reduce the feeding rate by 50% and add a prokinetic agent

Explanation: Current ASPEN/SCCM guidelines recommend against routine monitoring of gastric residual volumes, as GRV does not reliably correlate with aspiration risk, pneumonia, or feeding intolerance. If GRV is monitored, feedings should not be held for GRV less than 500 mL in the absence of other signs of intolerance. The focus should be on clinical signs such as vomiting, abdominal distension, and diarrhea.

7What is the most common metabolic complication of refeeding syndrome?

A.Hypernatremia

B.Hypophosphatemia

C.Hyperkalemia

D.Hypercalcemia

Explanation: Hypophosphatemia is the hallmark metabolic abnormality of refeeding syndrome. When malnourished patients receive carbohydrate nutrition, insulin secretion drives phosphate intracellularly for ATP and 2,3-DPG synthesis. This can cause severe hypophosphatemia, leading to respiratory failure, cardiac dysfunction, rhabdomyolysis, and death if not identified and corrected promptly.

8According to USP <797>, what is the maximum beyond-use date (BUD) for a compounded sterile preparation (CSP) prepared under Category 2 conditions and stored at controlled room temperature?

A.12 hours

B.24 hours

C.4 days

D.28 days

Explanation: Under USP <797> (revised 2023), Category 2 CSPs prepared in a cleanroom meeting ISO Class 5 PEC within an ISO Class 7 buffer area have a maximum BUD of 4 days at controlled room temperature (20-25°C). These conditions require more stringent environmental monitoring and personnel training than Category 1.

9A patient receiving parenteral nutrition develops metabolic alkalosis. Which component of the PN formulation should be adjusted?

A.Increase sodium acetate and decrease sodium chloride

B.Increase sodium chloride and decrease sodium acetate

C.Increase calcium gluconate

D.Decrease dextrose concentration

Explanation: Acetate is metabolized to bicarbonate in the body. If a patient develops metabolic alkalosis, the acetate content in PN should be reduced and replaced with chloride salts. Conversely, metabolic acidosis is managed by increasing acetate and decreasing chloride. Manipulating the chloride-to-acetate ratio is a standard PN intervention for acid-base management.

10Which trace element deficiency is most likely in a patient receiving long-term parenteral nutrition who presents with dysgeusia, alopecia, and perioral dermatitis?

A.Copper

B.Selenium

C.Zinc

D.Chromium

Explanation: Zinc deficiency classically presents with dysgeusia (altered taste), alopecia (hair loss), perioral and acral dermatitis, impaired wound healing, and diarrhea. Patients on long-term PN are at risk for zinc deficiency, especially with high GI output losses. Zinc requirements may need to be increased by 12 mg/L of small bowel output and 17 mg/kg of stool or ileostomy output.

About the BCNSP Exam

The BCNSP certification validates advanced knowledge in nutrition support pharmacy, covering parenteral and enteral nutrition, nutrition assessment, and therapeutic management. The Feb 2025 exam specifications define 150 items (125 scored + 25 unscored) across three domains: Nutrition Support (21%), Therapeutics and Patient Management (53%), and Professional Practice (26%).

Questions

150 scored questions

Time Limit

3 hours 45 minutes

Passing Score

Scaled (200-800, criterion-referenced)

Exam Fee

$600 (Board of Pharmacy Specialties (BPS))

BCNSP Exam Content Outline

21%

Nutrition Support

Normal and abnormal nutrition, parenteral nutrition sterile compounding (USP <797>), enteral nutrition formulations, and nutrition support delivery technology

53%

Therapeutics and Patient Management

Treatment planning, nutrition assessment, clinical assessment, pharmacokinetics, therapeutic implementation (PN/EN/oral), and treatment outcomes monitoring

26%

Professional Practice

Clinical practice guidelines (ASPEN/SCCM), medication safety, quality management, clinical informatics, pharmacoeconomics, and research methods

How to Pass the BCNSP Exam

What You Need to Know

Passing score: Scaled (200-800, criterion-referenced)
Exam length: 150 questions
Time limit: 3 hours 45 minutes
Exam fee: $600

Keys to Passing

Complete 500+ practice questions
Score 80%+ consistently before scheduling
Focus on highest-weighted sections
Use our AI tutor for tough concepts

BCNSP Study Tips from Top Performers

1Focus 53% of study time on therapeutics: PN/EN management, clinical assessment, and monitoring

2Master parenteral nutrition calculations: calories per gram of dextrose (3.4), amino acids (4), and lipid (10 for 20% IVLE)

3Review ASPEN/SCCM 2016 critical care nutrition guidelines and the 2023 malnutrition diagnostic criteria

4Study USP <797> sterile compounding standards including beyond-use dating and environmental monitoring

5Practice refeeding syndrome identification and management, including electrolyte correction protocols

Frequently Asked Questions

How many questions are on the BCNSP exam?

The BCNSP exam contains 150 total questions: 125 scored items and 25 unscored (pretest) items. Candidates cannot distinguish scored from unscored items during the exam.

How long is the BCNSP exam?

The BCNSP exam allows 3 hours and 45 minutes of testing time, effective with the February 2025 examination specifications update.

What score do I need to pass the BCNSP exam?

BPS uses scaled scoring on a 200-800 scale with a criterion-referenced passing standard. The passing score is determined by the BPS Specialty Council through a modified Angoff method, not a fixed percentage.

How much does the BCNSP exam cost?

The initial BCNSP certification application fee is $600. The retake fee is $300. Annual certification maintenance fees of $125 apply during years 1-6 of the 7-year certification cycle.

What are the BCNSP eligibility requirements?

Eligibility requires: (1) ACPE-accredited PharmD, (2) active pharmacist license, and (3) either 3 years practice with 50%+ time in nutrition support pharmacy activities or completion of a PGY2 residency in Nutrition Support Pharmacy.

How should I prepare for the BCNSP exam in 2026?

Focus on the 53% therapeutics domain first. Study ASPEN/SCCM guidelines, master PN calculations and compatibility, review enteral formula selection, and practice refeeding syndrome and electrolyte management scenarios.

100+ Free BCNSP Practice Questions

BPS BCNSP Board Certified Nutrition Support Pharmacist

Explore More BPS Pharmacy Specialty Certifications

BCPS

BCACP

BCOP Board Certified Oncology Pharmacist

BCCCP

BCCP Board Certified Cardiology Pharmacist

BCEMP Board Certified Emergency Medicine Pharmacist